Table 2.
Results of MIC obtained with fluoroquinolones and mutations identified in gyrA, gyrB, parC, and parE among S. epidermidis strains isolated from the infected eye and healthy conjunctiva.
| Strain designation (no. of strains) from | MIC of fluoroquinolones (mg/L) | QRDR showing mutation in genes for | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Infected eye | Healthy Conjunctiva | MXF | GAT | OFX | CIP | gyrA | gyrB | parC | parE |
| 409, 1520, 1429 (3) | N69OD (1) | 4 | 4 | 32 | >64 | S84 → F | NIL | S80 → F | NIL |
| – | N63OD, N95OS (2) | 1 | 2 | 8 | 4 | ||||
| 1362 (1) | – | 0.5 | 2 | 16 | >64 | ||||
| 1497 (1) | – | >64 | >64 | >64 | 32 | ||||
| 1558 (1) | – | 2 | 16 | 16 | 32 | ||||
| 1606 (1) | – | 2 | 32 | 2 | 2 | ||||
| – | N64OS (1) | 2 | 2 | 16 | 16 | ||||
| 108, 1121, 1184, 1515 (4) | – | 4 | 4 | 32 | >64 | S84 → F | NIL | S80 → F | NIL |
| D84 → C* | |||||||||
| 866, 1001, 1386 (3) | – | 4 | 4 | 32 | >64 | S84 → Y | NIL | S80 → Y | NIL |
| – | N80OS (1) | >64 | >64 | >64 | >64 | ||||
| – | N89OS (1) | 2 | 2 | 8 | 4 | ||||
| 1142W (1) | – | 1 | 1 | 2 | 32 | NIL | NIL | NIL | N404 → S |
| – | N78OD (1) | 2 | 4 | 8 | 4 | ||||
| 1502 (1) | N79OS (1) | 4 | 8 | >64 | >64 | S84 → Y | S80 → F | ||
| – | N3OD (1) | >64 | >64 | >64 | >64 | S84 → F | NIL | S80 → Y | NIL |
| – | N67OS (1) | 2 | 4 | 16 | 16 | ||||
| – | N74OS, N101OD (2) | 2 | 2 | 16 | 16 | S84 → F | NIL | NIL | NIL |
| – | N91OD, N93OSW (2) | 0.25 | 0.25 | 1 | 1 | NIL | NIL | D84 → A | NIL |
| 1033 (1) | – | 2 | 1 | 32 | >64 | S84 → F | NIL | S80 → F | NIL |
| V82 → L* | |||||||||
| D84 → C* | |||||||||
| 1122 (1) | – | >64 | >64 | >64 | 8 | S84 → F | NIL | NIL | N404 → S |
| 1123 (1) | – | 1 | 2 | 16 | 1 | S84 → F | NIL | S80 → F | N404 → S |
| 1056 (1) | – | 2 | 2 | >64 | >64 | S84 → F | NIL | D84 → Y | N404 → S |
| 1150 (1) | – | 4 | 4 | 32 | 8 | S84 → F | NIL | D84 → Y | N404 → S |
| – | N96OD (1) | 32 | 32 | >64 | 64 | S84 → Y | NIL | NIL | NIL |
| – | N98OD (1) | 0.125 | 0.125 | 0.25 | 0.25 | NIL | NIL | S80 → F | NIL |
| 1163, 1528 (2) | N1OD, N5OD, N6OS, N16OD, N18OD, N41OD, N46OD, N47OD, N52OD, N53OS, N81OD, N85OD, N94OD (13) | 0.125 | 0.125 | 0.5 | 0.25 | NIL | NIL | NIL | NIL |
MXF, Moxifloxacin; GAT, Gatifloxacin; OFX, Ofloxacin; CIP, Ciprofloxacin. Resistant: Bold; Intermediate: Bold italic; Sensitive: Normal.
Novel mutations found in this study.